296 related articles for article (PubMed ID: 32058159)
21. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
Knowles EJ; Menzies-Gow NJ; Mair TS
Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
[TBL] [Abstract][Full Text] [Related]
22. Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction.
Hart KA; Kitchings KM; Kimura S; Norton NA; Myrna KE
Am J Vet Res; 2016 Nov; 77(11):1236-1244. PubMed ID: 27805438
[TBL] [Abstract][Full Text] [Related]
23. Effect of delayed plasma centrifugation on equine adrenocorticotropic hormone concentration.
Shepard KN; Haffner JC; Neal DL; Grubbs ST; Pearce GL
J Vet Diagn Invest; 2019 Jul; 31(4):585-587. PubMed ID: 31246158
[TBL] [Abstract][Full Text] [Related]
24. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.
Rendle DI; Duz M; Beech J; Parkin T; Durham AE
J Vet Intern Med; 2015 Jan; 29(1):355-61. PubMed ID: 25312676
[TBL] [Abstract][Full Text] [Related]
25. Computed tomographic findings in the pituitary gland and brain of horses with pituitary pars intermedia dysfunction.
Pease AP; Schott HC; Howey EB; Patterson JS
J Vet Intern Med; 2011; 25(5):1144-51. PubMed ID: 21985144
[TBL] [Abstract][Full Text] [Related]
26. Lumbar vertebral bone density is decreased in horses with pituitary pars intermedia dysfunction.
Colbath AC; Fortin JS; Burglass CM; Panek C; Vergara-Hernandez FB; Johnson TN; Robison CA; Logan AA; Nelson NA; Nielsen BD; Schott HC
Equine Vet J; 2024 Mar; 56(2):368-376. PubMed ID: 38151767
[TBL] [Abstract][Full Text] [Related]
27. Perianesthetic development of diaphragmatic hernia in a horse with equine pituitary pars intermedia dysfunction (PPID).
Shepard MK; Lee WL; Eggleston RB
Can Vet J; 2015 Jan; 56(1):48-52. PubMed ID: 25565714
[TBL] [Abstract][Full Text] [Related]
28. Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses.
Kam YN; McKenzie K; Coyle M; Bertin FR
J Vet Intern Med; 2021 Nov; 35(6):2885-2890. PubMed ID: 34642962
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
[TBL] [Abstract][Full Text] [Related]
30. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.
Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N
J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
Beech J; Boston RC; McFarlane D; Lindborg S
J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
[TBL] [Abstract][Full Text] [Related]
32. Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses.
McFarlane D; Cribb AE
Am J Vet Res; 2005 Dec; 66(12):2065-72. PubMed ID: 16379648
[TBL] [Abstract][Full Text] [Related]
33. Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction.
Huang L; Palmieri C; Bertin FR
Res Vet Sci; 2022 Dec; 152():427-433. PubMed ID: 36126509
[TBL] [Abstract][Full Text] [Related]
34. Gene expression of proteolytic systems and growth regulators of skeletal muscle in horses with myopathy associated with pituitary pars intermedia dysfunction.
Aleman M; Nieto JE
Am J Vet Res; 2010 Jun; 71(6):664-70. PubMed ID: 20513182
[TBL] [Abstract][Full Text] [Related]
35. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of dynamic testing for pituitary pars intermedia dysfunction diagnosis in donkeys.
Mejia-Pereira S; Perez-Ecija A; Buchanan BR; Toribio RE; Mendoza FJ
Equine Vet J; 2019 Jul; 51(4):481-488. PubMed ID: 30362589
[TBL] [Abstract][Full Text] [Related]
37. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
McFarlane D; Beech J; Cribb A
Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
[TBL] [Abstract][Full Text] [Related]
38. Basal glucose metabolism and peripheral insulin sensitivity in equine pituitary pars intermedia dysfunction.
Klinkhamer K; Menheere PP; van der Kolk JH
Vet Q; 2011 Mar; 31(1):19-28. PubMed ID: 22029818
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of equine pituitary pars intermedia dysfunction.
Stewart AJ; Ireland JL; Durham AE; McGowan CM
Vet J; 2023; 300-302():106036. PubMed ID: 37805159
[TBL] [Abstract][Full Text] [Related]
40. Equine pituitary pars intermedia dysfunction.
McFarlane D
Vet Clin North Am Equine Pract; 2011 Apr; 27(1):93-113. PubMed ID: 21392656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]